Long-term management of bilateral, multifocal, recurrent renal carcinoma

Nature Reviews Urology

Volumn 7, Issue 5, 2010, Pages 267-275

  Bratslavsky, Gennady ^a   Linehan, W Marston ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CLINICAL OBSERVATION; HUMAN; KIDNEY CARCINOMA; KIDNEY TRANSPLANTATION; LONG TERM CARE; MEDICAL DECISION MAKING; MULTIPLE CANCER; NEPHRECTOMY; NEPHRON SPARING SURGERY; OUTCOME ASSESSMENT; PERIOPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; RENAL REPLACEMENT THERAPY; REOPERATION; REVIEW; SURGICAL MORTALITY;

ALGORITHMS; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; RENAL REPLACEMENT THERAPY; REOPERATION;

EID: 77952275926     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.44     Document Type: Review

References (84)

1. Jemal, A. et al. Cancer statistics, 2009. CA Cancer J. Clin. 59, 225-249 (2009).
2. Chow, W. H., Devesa, S. S., Warren, J. L. & Fraumeni, J. F. Jr. Rising incidence of renal cell cancer in the United States. JAMA 281, 1628-1631 (1999).
3. Hollingsworth, J. M., Miller, D. C., Daignault, S. & Hollenbeck, B. K. Rising incidence of small renal masses: a need to reassess treatment effect. J. Natl Cancer Inst. 98, 1331-1334 (2006).
4. Janzen, N. K., Kim, H. L., Figlin, R. A. & Belldegrun, A. S. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol. Clin. North Am. 30, 843-852 (2003).
5. Lam, J. S., Leppert, J. T., Figlin, R. A. & Belldegrun, A. S. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr. Urol. Rep. 6, 7-18 (2005).
6. Levy, D. A., Slaton, J. W., Swanson, D. A. & Dinney, C. P. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J. Urol. 159, 1163-1167 (1998).
7. Stephenson, A. J. et al. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J. Urol. 172, 58-62 (2004).
8. Steinbach, F. et al. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J. Urol. 153, 1812-1816 (1995).
9. Blute, M. L. et al. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. J. Urol. 169, 1276-1281 (2003).
10. Boorjian, S. A., Crispen, P. L., Lohse, C. M., Leibovich, B. C. & Blute, M. L. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Eur. Urol. 54, 855-863 (2008).
11. Klatte, T. et al. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int. 100, 21-25 (2007).
12. Krambeck, A. et al. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery. BJU Int. 101, 1375-1379 (2008).
13. Gnarra, J. R. et al. Molecular genetic studies of sporadic and familial renal cell carcinoma. Urol. Clin. North Am. 20, 207-216 (1993).
14. Linehan, W. M. et al. Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin. Cancer Res. 10, 6282S-6289S (2004).
15. Linehan, W. M. Genetic basis of bilateral renal cancer: implications for evaluation and management. J. Clin. Oncol. 27, 3731-3733 (2009).
16. Blute, M. L., Amling, C. L., Bryant, S. C. & Zincke, H. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease. Mayo Clin. Proc. 75, 1020-1026 (2000).
17. Crispen, P. L., Lohse, C. M. & Blute, M. L. Multifocal renal cell carcinoma: clinicopathologic features and outcomes for tumors
18. Dimarco, D. S., Lohse, C. M., Zincke, H., Cheville, J. C. & Blute, M. L. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Urology 64, 462-467 (2004).
19. Lang, H. et al. Prognostic value of multifocality on progression and survival in localized renal cell carcinoma. Eur. Urol. 45, 749-753 (2004).
20. Lowrance, W. T. et al. Developments in the surgical management of sporadic synchronous bilateral renal tumours. BJU Int. doi:10.1111/j.1464-410X. 2009.08844.x.
21. Patel, M. I. et al. Long-term follow-up of bilateral sporadic renal tumors. Urology 61, 921-925 (2003).
22. Richstone, L. et al. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. J. Urol. 171, 615-620 (2004).
23. Grimaldi, G., Reuter, V. & Russo, P. Bilateral nonfamilial renal cell carcinoma. Ann. Surg. Oncol. 5, 548-552 (1998). (Pubitemid 28421756)
24. Siemer, S. et al. Bilateral kidney tumor. Therapy management and histopathological results with long-term follow-up of 66 patients [German]. Urologe A 40, 114-120 (2001).
25. Zincke, H. & Swanson, S. K. Bilateral renal cell carcinoma: influence of synchronous and asynchronous occurrence on patient survival. J. Urol. 128, 913-915 (1982).
26. Wunderlich, H. et al. Multifocality in renal cell carcinoma: a bilateral event? Urol. Int. 63, 160-163 (1999). (Pubitemid 30083820)
27. Klatte, T. et al. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. J. Urol. 177, 2081-2086 (2007).
28. Baltaci, S. et al. Influence of tumor stage, size, grade, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma. J. Urol. 164, 36-39 (2000).
29. Cheng, W. S., Farrow, G. M. & Zincke, H. The incidence of multicentricity in renal cell carcinoma. J. Urol. 146, 1221-1223 (1991).
30. Gohji, K. et al. Multifocal renal cell carcinoma in Japanese patients with tumors with maximal diameters of 50 mm or less. J. Urol. 159, 1144-1147 (1998).
31. Junker, K. et al. Clonal origin of multifocal renal cell carcinoma as determined by microsatellite analysis. J. Urol. 168, 2632-2636 (2002).
32. Karayiannis, A., Varkarakis, I., Chort, M., Alivizatos, G. & Fragiskos, S. Multifocality of renal cell tumors is a factor to consider before performing a partial nephrectomy. Anticancer Res. 22, 3103-3107 (2002).
33. Kletscher, B. A., Qian, J., Bostwick, D. G., Andrews, P. E. & Zincke, H. Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J. Urol. 153, 904-906 (1995).
34. Mukamel, E., Konichezky, M., Engelstein, D. & Servadio, C. Incidental small renal tumors accompanying clinically overt renal cell carcinoma. J. Urol. 140, 22-24 (1988).
35. Nissenkorn, I. & Bernheim, J. Multicentricity in renal cell carcinoma. J. Urol. 153, 620-622 (1995).
36. Oya, M., Nakamura, K., Baba, S., Hata, J. & Tazaki, H. Intrarenal satellites of renal cell carcinoma: histopathologic manifestation and clinical implication. Urology 46, 161-164 (1995).
37. Saiki, S. et al. Multicentricity and concomitant tumors in renal cell carcinoma: analysis by serial section of resected kidneys [Japanese]. Hinyokika Kiyo 41, 725-729 (1995).
38. Schlichter, A., Schubert, R., Werner, W., Zermann, D. H. & Schubert, J. How accurate is diagnostic imaging in determination of size and multifocality of renal cell carcinoma as a prerequisite for nephron-sparing surgery? Urol. Int. 64, 192-197 (2000).
39. Whang, M. et al. The incidence of multifocal renal cell carcinoma in patients who are candidates for partial nephrectomy. J. Urol. 154, 968-970 (1995).
40. Ljungberg, B., Alamdari, F. I., Rasmuson, T. & Roos, G. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int. 84, 405-411 (1999).
41. Walther, M. M., Lubensky, I. A., Venzon, D., Zbar, B. & Linehan, W. M. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J. Urol. 154, 2010-2014 (1995).
42. Ornstein, D. K. et al. Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer. J. Urol. 163, 431-433 (2000).
43. Pavlovich, C. P. et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am. J. Surg. Pathol. 26, 1542-1552 (2002).
44. Fetner, C. D., Barilla, D. E., Scott, T., Ballard, J. & Peters, P. Bilateral renal cell carcinoma in von Hippel-Lindau syndrome: treatment with staged bilateral nephrectomy and hemodialysis. J. Urol. 117, 534-536 (1977).
45. Pearson, J. C., Weiss, J. & Tanagho, E. A. A plea for conservation of kidney in renal adenocarcinoma associated with von Hippel- Lindau disease. J. Urol. 124, 910-912 (1980).
46. Berg, S. et al. The surgical management of hereditary multifocal renal carcinoma. J. Urol. 126, 313-315 (1981).
47. Frydenberg, M., Malek, R. S. & Zincke, H. Conservative renal surgery for renal cell carcinoma in von Hippel-Lindau's disease. J. Urol. 149, 461-464 (1993).
48. Loughlin, K. R. & Gittes, R. F. Urological management of patients with von Hippel- Lindau's disease. J. Urol. 136, 789-791 (1986).
49. Lund, G. O., Fallon, B., Curtis, M. A. & Williams, R. D. Conservative surgical therapy of localized renal cell carcinoma in von Hippel- Lindau disease. Cancer 74, 2541-2545 (1994).
50. Malek, R. S., Omess, P. J., Benson, R. C. Jr & Zincke, H. Renal cell carcinoma in von Hippel- Lindau syndrome. Am. J. Med. 82, 236-238 (1987).
51. Walther, M. M. et al. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma. J. Urol. 153, 913-916 (1995).
52. Foley, D. P. et al. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida. Clin. Transpl. 101-109 (2005).
53. Hernandez, D. et al. Predicting delayed graft function and mortality in kidney transplantation. Transplant. Rev. (Orlando) 22, 21-26 (2008).
54. Schold, J., Srinivas, T. R., Sehgal, A. R. & Meier-Kriesche, H. U. Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin. J. Am. Soc. Nephrol. 4, 1239-1245 (2009).
55. Kasiske, B. L. et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am. J. Transplant. 1 (Suppl. 2), 3-95 (2001).
56. United States Renal Data System. 2007 Annual Data Report, Bethesda, MD. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), US Department of Health and Human Services (DHHS) (2007).
57. Lin, S. J. et al. The association between length of post-kidney transplant hospitalization and long-term graft and recipient survival. Clin. Transplant. 20, 245-252 (2006).
58. Rocco, M. V., Frankenfield, D. L., Hopson, S. D. & McClellan, W. M. Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann. Intern. Med. 145, 512-519 (2006).
59. Foley, R. N., Parfrey, P. S. & Sarnak, M. J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32, S112-S119 (1998).
60. Neil, N. et al. The financial implications for Medicare of greater use of peritoneal dialysis. Clin. Ther. 31, 880-888 (2009).
61. Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296-1305 (2004).
62. Huang, W. C. et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 7, 735-740 (2006).
63. Huang, W. C., Elkin, E. B., Levey, A. S., Jang, T. L. & Russo, P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors-is there a difference in mortality and cardiovascular outcomes? J. Urol. 181, 55-61 (2009).
64. Thompson, R. H. et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J. Urol. 179, 468-471 (2008).
65. Sarnak, M. J. et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108, 2154-2169 (2003).
66. Weiner, D. E. et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am. J. Kidney Dis. 48, 392-401 (2006).
67. Koenig, P. et al. Kidney cancer and the risk for chronic kidney disease: matched-paired comparison with living donors [abstract]. J. Urol. 179, 171 (2009).
68. Hwang, J. J. et al. Radio frequency ablation of small renal tumors: intermediate results. J. Urol. 171, 1814-1818 (2004).
69. Walther, M. C. et al. A phase 2 study of radio frequency interstitial tissue ablation of localized renal tumors. J. Urol. 163, 1424-1427 (2000).
70. Kowalczyk, K. J. et al. Partial nephrectomy after previous radio frequency ablation: The National Cancer Institute Experience. J. Urol. 182, 2158-2163 (2009).
71. Bratslavsky, G. et al. Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J. Urol. 179, 67-70 (2008).
72. Johnson, A. et al. Feasibility and outcomes of repeat partial nephrectomy. J. Urol. 180, 89-93 (2008).
73. Herring, J. C. et al. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J. Urol. 165, 777-781 (2001).
74. Ghavamian, R. et al. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J. Urol. 168, 454-459 (2002).
75. Saranchuk, J. W., Touijer, A. K., Hakimian, P., Snyder, M. E. & Russo, P. Partial nephrectomy for patients with a solitary kidney: the Memorial Sloan-Kettering experience. BJU Int. 94, 1323-1328 (2004).
76. Thompson, R. H., Leibovich, B. C., Lohse, C. M., Zincke, H. & Blute, M. L. Complications of contemporary open nephron sparing surgery: a single institution experience. J. Urol. 174, 855-868 (2005).
77. Magera, J. S. Jr et al. Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant. J. Urol. 179, 853-856 (2008).
78. Stephenson, A. J., Hakimi, A. A., Snyder, M. E. & Russo, P. Complications of radical and partial nephrectomy in a large contemporary cohort. J. Urol. 171, 130-134 (2004).
79. Nguyen, C. T. et al. Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy. J. Urol. 180, 104-109 (2008).
80. Liu, N. W. et al. Repeat partial nephrectomy on the solitary kidney: surgical, functional, and oncologic outcomes. J. Urol. (in press).
81. Walther, M. M. et al. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J. Urol. 161, 1475-1479 (1999).
82. Duffey, B. G. et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J. Urol. 172, 63-65 (2004).
83. Choyke, P. L. et al. Intraoperative ultrasound during renal parenchymal sparing surgery for hereditary renal cancers: a 10-year experience. J. Urol. 165, 397-400 (2001).
84. Walther, M. M. et al. Evaluation of color Doppler intraoperative ultrasound in parenchymal sparing renal surgery. J. Urol. 152, 1984-1987 (1994).